Back to
BROWN BROTHERS HARRIMAN & CO
KRYS
Showing 0 of 4 quarters
Position history for
BROWN BROTHERS HARRIMAN & CO's holdings in KRYSTAL BIOTECH INC
No. Brown Brothers Harriman exited its KRYS (Krystal Biotech) position in Q1 2021. Its Q4 2020 13F listed 27,000 shares worth $1.6M. Brown Brothers Harriman first reported KRYS in Q2 2020 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.